
IDEXX Laboratories (IDXX) Stock Forecast & Price Target
IDEXX Laboratories (IDXX) Analyst Ratings
Bulls say
IDEXX Laboratories is positioned to experience continuous growth in the animal health diagnostics and services industry, leveraging their global leadership in the sector. With a strong commercial organization and a diverse and synergistic product portfolio, including innovative new tests and software services, the company is well-positioned for future success. Despite facing some headwinds, such as competition and current macroeconomic pressures, IDXX has shown strong financial performance, indicating its ability to adapt and thrive in challenging circumstances. As such, the analyst maintains a positive outlook on the company's stock.
Bears say
IDEXX Laboratories is viewed negatively by analysts due to a combination of industry headwinds, including staffing shortages and inflation, that have resulted in slower growth for the animal health industry. While IDEXX has been able to outpace sector growth due to its strong value proposition, customer engagement, and unique solutions, there is a risk that the company's stock valuation may pull back and trade more in line with other diagnostics or medical technology companies. Additionally, the recent CEO transition from Jay Mazelsky to Mike Erickson may cause some uncertainty and could potentially impact the company's performance in the short term.
This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.
IDEXX Laboratories (IDXX) Analyst Forecast & Price Prediction
Start investing in IDEXX Laboratories (IDXX)
Order type
Buy in
Order amount
Est. shares
0 shares